High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.

Fehr M, Hawle H, Hayoz S, Thuss-Patience P, Schacher S, Riera Knorrenschild J, Dürr D, Knoefel WT, Rumpold H, Bitzer M, Zweifel M, Samaras P, Mey U, Küng M, Winterhalder R, Eisterer W, Hess V, Gérard MA, Templeton A, Stahl M, Ruhstaller T, Swiss Group for Clinical Cancer Research (SAKK), German Esophageal Cancer Study Group, Austrian Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT), Fédération Francophone de Cancérologie Digestive (FFCD) / Fédération de Recherche en Chirurgie (FRENCH)

Open source

DOI
10.1186/s12885-020-6623-z
Published
2020 Feb 28
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-020-6623-z,
  title = {High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.},
  author = {Fehr M and Hawle H and Hayoz S and Thuss-Patience P and Schacher S and Riera Knorrenschild J and Dürr D and Knoefel WT and Rumpold H and Bitzer M and Zweifel M and Samaras P and Mey U and Küng M and Winterhalder R and Eisterer W and Hess V and Gérard MA and Templeton A and Stahl M and Ruhstaller T and Swiss Group for Clinical Cancer Research (SAKK) and German Esophageal Cancer Study Group and Austrian Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT) and Fédération Francophone de Cancérologie Digestive (FFCD) / Fédération de Recherche en Chirurgie (FRENCH)},
  year = {2020},
  journal = {BMC cancer},
  doi = {10.1186/s12885-020-6623-z},
  url = {https://doi.org/10.1186/s12885-020-6623-z}
}

RIS

TY  - JOUR
TI  - High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.
AU  - Fehr M
AU  - Hawle H
AU  - Hayoz S
AU  - Thuss-Patience P
AU  - Schacher S
AU  - Riera Knorrenschild J
AU  - Dürr D
AU  - Knoefel WT
AU  - Rumpold H
AU  - Bitzer M
AU  - Zweifel M
AU  - Samaras P
AU  - Mey U
AU  - Küng M
AU  - Winterhalder R
AU  - Eisterer W
AU  - Hess V
AU  - Gérard MA
AU  - Templeton A
AU  - Stahl M
AU  - Ruhstaller T
AU  - Swiss Group for Clinical Cancer Research (SAKK)
AU  - German Esophageal Cancer Study Group
AU  - Austrian Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT)
AU  - Fédération Francophone de Cancérologie Digestive (FFCD) / Fédération de Recherche en Chirurgie (FRENCH)
PY  - 2020
JO  - BMC cancer
DO  - 10.1186/s12885-020-6623-z
UR  - https://doi.org/10.1186/s12885-020-6623-z
ER  - 

APA

M, F., H, H., S, H., P, T., S, S., J, R. K., D, D., WT, K., H, R., M, B., M, Z., P, S., U, M., M, K., R, W., W, E., V, H., MA, G., A, T., M, S., T, R., (SAKK), S. G. F. C. C. R., Group, G. E. C. S., (AGMT), A. A. M. T., & (FRENCH), F. F. D. C. D. (. /. F. D. R. E. C. (2020). High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.. BMC cancer. https://doi.org/10.1186/s12885-020-6623-z

Source records